4-1BB Targeting Immunotherapy: Mechanism, Antibodies, and Chimeric Antigen Receptor T
Article in Cancer Biotherapy & Radiopharmaceuticals (July 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Chk1 inhibitor-induced DNA damage increases BFL1 and decreases BIM but does not protect human cancer cell lines from Chk1 inhibitor-induced apoptosis.
Article in American Journal of Cancer Research (May 2022)
The enhancer rare germline variation rs548071605 contributes to lung cancer development
Article in Human Mutation (December 2021)